Analysts Offer Predictions for Ashland FY2027 Earnings

Ashland Inc. (NYSE:ASH) – Investment analysts at Seaport Res Ptn decreased their FY2027 earnings estimates for shares of Ashland in a report issued on Wednesday, November 5th. Seaport Res Ptn analyst M. Harrison now forecasts that the basic materials company will earn $4.83 per share for the year, down from their prior estimate of $5.38. The consensus estimate for Ashland’s current full-year earnings is $4.27 per share.

Several other research analysts have also issued reports on the company. Zacks Research lowered Ashland from a “hold” rating to a “strong sell” rating in a research report on Friday, October 24th. Morgan Stanley began coverage on Ashland in a report on Monday, September 8th. They set an “equal weight” rating and a $60.00 target price on the stock. Evercore ISI decreased their target price on Ashland from $62.00 to $53.00 and set an “in-line” rating for the company in a research report on Tuesday. Weiss Ratings reiterated a “sell (d)” rating on shares of Ashland in a research report on Wednesday, October 8th. Finally, Mizuho decreased their price objective on shares of Ashland from $58.00 to $54.00 and set an “outperform” rating for the company in a report on Friday, October 3rd. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $59.38.

Ashland Price Performance

ASH opened at $50.05 on Monday. The company has a fifty day moving average price of $50.09 and a two-hundred day moving average price of $51.23. The firm has a market capitalization of $2.29 billion, a PE ratio of -2.67, a P/E/G ratio of 11.41 and a beta of 0.49. Ashland has a 52 week low of $45.21 and a 52 week high of $80.94. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.33 and a current ratio of 2.68.

Ashland (NYSE:ASH) last issued its quarterly earnings results on Thursday, June 9th. The basic materials company reported $0.56 EPS for the quarter. Ashland had a negative net margin of 46.01% and a positive return on equity of 6.82%. The company had revenue of $509.00 million during the quarter. Ashland has set its FY 2022 guidance at EPS.

Institutional Trading of Ashland

Several hedge funds have recently bought and sold shares of ASH. Rothschild Investment LLC boosted its holdings in shares of Ashland by 3,673.3% in the third quarter. Rothschild Investment LLC now owns 566 shares of the basic materials company’s stock valued at $27,000 after buying an additional 551 shares during the period. Geneos Wealth Management Inc. lifted its position in Ashland by 59.0% in the 2nd quarter. Geneos Wealth Management Inc. now owns 671 shares of the basic materials company’s stock valued at $34,000 after acquiring an additional 249 shares in the last quarter. Abound Wealth Management acquired a new position in Ashland in the 2nd quarter worth $40,000. Allworth Financial LP increased its holdings in Ashland by 63.9% during the 1st quarter. Allworth Financial LP now owns 834 shares of the basic materials company’s stock worth $49,000 after purchasing an additional 325 shares in the last quarter. Finally, State of Wyoming bought a new position in Ashland during the 3rd quarter worth about $57,000. 93.95% of the stock is currently owned by institutional investors and hedge funds.

About Ashland

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.